Clinical trials
Cognitive Dysfunction trials in Canada with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 3 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baycrest | 4 |
| Sunnybrook Health Sciences Centre | 2 |
| University of British Columbia | 2 |
| University of Manitoba | 2 |
| Bio Conscious Technologies Inc. | 1 |
| Bruyère Health Research Institute. | 1 |
| CHU de Quebec-Universite Laval | 1 |
| Dr. Gordon Boyd | 1 |
| Dr. Richard H. Swartz | 1 |
| Immunotec Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 27 |
| Alzheimer Disease | 6 |
| Dementia | 5 |
| Delirium | 2 |
| Frailty | 2 |
| Ischemic Attack, Transient | 2 |
| Parkinson Disease | 2 |
| Anxiety Disorders | 1 |
| Cognition Disorders | 1 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.